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Summary
Background:  The  rapid  spread  of  metallo--lactamase  producing  clinical  pathogens
is  a  matter  of  great  concern  and  with  the  addition  of  NDM-1  it  poses  more  threat  for
public  health  as  NDM-1  positive  isolates  show  resistance  to  most  of  the  antibiotics.
The  current  study  was  carried  out  to  determine  the  prevalence  of  extended-
spectrum  -lactamases  (ESBLs)  and  metallo--lactamases  (MBLs),  particularly  NDM-1
in  clinical  multi-drug  resistant  isolates  from  two  tertiary  care  hospitals  in  Pakistan.
Methods:  A  total  of  356  clinical  isolates  were  included  in  the  study  where  301  isolates
were  collected  from  the  Pakistan  Institute  of  Medical  Sciences  (PIMS),  Islamabad  and
55  were  collected  from  the  Mayo  Hospital  Lahore.  The  isolates  were  screened  for
ESBLs  and  MBLs  production  by  phenotypic  method  and  PCR  was  performed  to  detect
the  presence  of  blaVIM, blaIMP and  blaNDM-1 genes.
Results:  Out  of  356  clinical  isolates,  160  showed  carbapenem  resistance.  Of  these
160  isolates,  131  displayed  MBLs  production  as  accessed  by  combined  disk  method.  In
MBLs  producing  organisms,  PCR  ampliﬁcation  conﬁrmed  31  (23.6%)  isolates  harboring
blaNDM-1 gene,  33  (25.1%)  isolates  having  blaVIM gene  and  2  (1.5%)  isolates  displaying
blaIMP gene.  Plasmid  proﬁle  analysis  of  NDM-1  positive  organisms  showed  variable
number  of  plasmids  which  were  stable  during  serial  passages  in  antibiotic  free  media.
The  prevalence  of  ESBL  producing  organisms  was  recorded  to  be  87.5%.
Conclusion:  The  results  show  a  high  level  of  NDM-1  positive  organisms  from  variety
of  samples  at  both  hospitals,  implicating  the  spread  of  MBL  genes  in  clinical  isolates.
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Ltd.  All  rights  reserved.
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Introduction
Carbapenem-hydrolyzing  -lactamases,  known  as
carbapenemases,  are  an  increasing  concern  for
global health-care  due  to  their  association  with
resistance  to  -lactam  antibiotics.  These  enzymes
are carried  either  on  chromosome  or  acquired
via plasmids.  Ambler  classiﬁcation  divides  -
lactamases  into  four  major  classes;  A,  B,  C  and  D.
Metallo--lactamases  (MBLs)  fall  in  class  B  and  are
further divided  into  three  subclasses:  B1,  B2,  and
B3 [1,2]  where  most  acquired  MBLs  belong  to  the
B1 class  except  AIM  and  SMB.  The  most  common
MBL enzymes  include  IMP,  VIM,  GIM,  SIM  [1]  and
NDM-1. The  carbapenemase,  New  Delhi  metallo-
-lactamase-1 (NDM-1),  was  ﬁrst  reported  in  2009
in Klebsiella  pneumoniae  and  Escherichia  coli  iso-
lates from  a  Swedish  patient  who  had  sought
medical care  in  New  Delhi,  India  [3]  though  a
retrospective  study  later  reported  that  NDM-1  pos-
itive organisms  were  disseminated  in  Indian  health
care facilities  in  2006  [4].  It  was  recently  shown
that NDM  gene  is  a  chimeric  molecule  and  is  a
result of  fusion  of  two  different  genes  [5]. Like
other acquired  MBLs,  NDM-1  can  hydrolyze  all  -
lactam drugs  except  aztreonam,  which  is mostly
inactivated  by  co-produced  extended-spectrum  -
lactamases  (ESBLs)  or  AmpC  -lactamases  [3]. The
co-existence  of  blaNDM-1 with  other  resistance  genes
makes the  majority  of  Enterobacteriaceae  highly
resistant  against  most  of  drugs  except  colistin  and
tigecycline.  Since  its  discovery  in  2009,  NDM-1
has been  disseminated  in  different  countries  and
is being  reported  globally  [6,7]. Because  of  its
association  with  Indian  sub-continent,  a  number
of studies  have  included  samples  from  Pakistan
and India  to  evaluate  the  prevalence  and  spread
of this  enzyme.  A  study  conducted  on  stool  sam-
ples from  patients  at  Military  hospitals  in  Pakistan
revealed an  overall  prevalence  of  18.5%  NDM-1
positive Enterobacteriaceae  [8]  with  27.1%  from
inpatients  while  13.8%  were  from  out  patients.
That study  was  conducted  to  evaluate  a chro-
mogenic media  and  was  focused  on  fecal  carriage
of Enterobacteriaceae  of  NDM-1  hence  included
only stool  samples.  The  present  study  was  car-
ried out  to  investigate  the  prevalence  of  ESBLs
and MBLs  carriage  in  different  clinical  samples.
The aim  was  to  isolate  gram  negative  pathogens
responsible for  various  infections,  and  investigate
the antibiotic  resistance  pattern  and  the  pres-
ence of  blaNDM-1 along  with  blaVIM and  blaIMP in
these isolates  in  order  to  estimate  the  impact
of MBLs  producing  pathogens  on  public  health
care.
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ethods
acterial isolates
 total  of  356  gram  negative  clinical  isolates  were
ollected  from  different  specimens  of  hospitalized
atients and  outpatients.  Fifty  ﬁve  isolates  were
ollected  from  the  Mayo  Hospital  Lahore  while  301
solates were  taken  from  the  Pakistan  Institute  of
edical sciences  (PIMS),  Islamabad,  Pakistan.  Of
ll isolates,  62%  were  from  inpatients  while  38%
ere from  outpatients.  Initial  identiﬁcation  of  the
athogens  was  done  by  gram  staining  and  growth
haracteristics  on  McConkey  agar  and  was  later  con-
rmed by  conventional  biochemical  tests.
henotypic detection of carbapenemases
or  the  phenotypic  detection  of  carbapenemase,
odiﬁed  Hodge  test  (MHT)  was  performed  on
ueller Hinton  agar  (MHA)  using  a 10  g  disk  of
eropenem according  to  Clinical  Laboratory  Stan-
ards Institute  (CLSI)  guidelines  [9]. After  18  h
ncubation  at  37 ◦C,  a clover  leaf-type  indenta-
ion at  the  intersection  of  test  organism  showed
 positive  result  (Fig.  1A).  Extended  spectrum  -
actamases  (ESBLs)  were  detected  by  disk  diffusion
ethod  [10]  following  Clinical  and  Laboratory  Stan-
ards Institute  (CLSI)  recommendations.  A  30  g
isk each  of  cefotaxime,  ceftazidime,  ceftriaxone
nd aztreonam  were  placed  at  20  mm  center  to
enter from  a  30  g  amoxicillin—calvulanic  acid
isk. After  18—24  h  incubation,  the  plates  were
bserved for  an  enhancement  in  zone  diameter
n the  area  between  any  of  the  four  disks  and
moxicillin—calvulanic  acid  disk  (Fig.  1B).  MBLs
ere detected  by  using  combined  disks  diffusion
ethod on  MHA  with  10  g  disk  of  meropenem
nd 0.5  M  EDTA  as  an  inhibitor.  After  18—24  h
ncubation, the  plates  were  observed  for  an
ncrease of  ≥7  mm  in  the  zone  of  inhibition  of
ombination  disks  compared  to  meropenem  disks
Fig.  1C).
olecular identiﬁcation of MBL genes using
CR
NAs  were  extracted  from  all  MBLs  produc-
ng strains  by  ethanol  precipitation  method.  For
laNDM-1 detection,  the  extracted  DNAs  were  sub-
ected to  single  target  PCR  using  forward  primer;
′ ′
′-TCGCGAAGCTGAGCA-3′ sequences  as  already
escribed in  literature  [7]. For  blaIMP and  blaVIM
he  primer  sequences  were  used  as  already
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Figure  1  Phenotypic  detection  of  carbapenemases.  (A)  Positive  Modiﬁed  Hodge  test  showing  a  clover  leaf-type  inden-
tation  at  the  intersection  of  test  organism.  (B)  Disk  diffusion  method  for  extended  spectrum  -lactamases  (ESBLs)
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wetection.  (C)  Combined  disks  diffusion  method  for  MBL  
escribed  in  literature  [11]. Brieﬂy,  for  blaIMP, for-
ard primer;  5′-GAATAGAATGGTTAACTCTC-3′ and
everse primer;  5′-CCAAACCACTAGGTTATC-3′ were
sed while  for  blaVIM detection  forward  primer;  5′-
TTTGGTCGCATATCGCAAC-3′ and  reverse  primer;
′-AATGCGCAGCACCAGGATAG-3′ were  used.  Ampli-
cation  products  were  visualized  under  UV  light  on
% agarose  gel  electrophoresis.
olecular identiﬁcation of blaNDM-1 gene on
lasmids
lasmids  DNA  were  isolated  using  plasmid  isolation
it (Norgen  BIOTEK)  following  the  manufacturer’s
uidelines.  The  DNAs  were  separated  on  0.7%
garose gel  in  TBE  buffer  along  with  DNA  ladder  of
 kb  (Fermentas)  as  size  reference.  The  presence
f blaNDM-1 on  plasmids  DNAs  was  detected  by  PCR
sing the  method  as  described  earlier.
lasmid stability assay
he  plasmids  of  NDM-1  positive  strains  were  tested
or stability.  Serial  passages  of  the  isolates  were
erformed  on  antibiotic  (meropenem)  free  and
.5 mg/L  meropenem  containing  media.  After  every
assage,  the  plasmid  DNA  was  extracted  and  sepa-
ated on  agarose  gel.
ntimicrobial susceptibility testing
he  isolates  were  tested  for  antimicrobial  suscep-
ibility  by  using  Kirby-bauer  method  according  to
LSI guidelines  [9]. E.  coli  ATCC  25922,  K.  pneu-
oniae ATCC  700603  and  Pseudomonas  aeruginosa
TCC 27853  strains  were  used  as  control  strains.
f
a
o
Tction.
esults
acterial Strains
ut  of  301  isolates  from  the  Pakistan  Institute  of
edical Sciences  (PIMS)  Hospital,  122  were  E.  coli,
8 were  P. aeruginosa, 69  were  K.  pneumonia, 9
ere Proteus  sp.  and  3  were  Enterobacter  sp.  Out
f 55  isolates  from  the  Mayo  Hospital,  23  were
. coli,  14  were  P.  aeruginosa, 13  were  K.  pneu-
onia and  5  were  Proteus  sp.
revalence of ESBL and MBL producing gram
egative clinical isolates
mong  all  isolates,  36.7%  produced  MBLs  as  shown
y phenotypic  test.  Among  112  isolates  of  P.
eruginosa, 38  (33.9%)  were  MBL  producers.  Among
2 isolates  of  K.  pneumoniae, 37  (45.12%)  were  pos-
tive for  MBL  production.  Of  145  isolates  of  E. coli,
0 (34.48%)  were  MBL  producers.  The  prevalence
f ESBLs  as  accessed  by  phenotypic  test  and  antibi-
tic resistance  to  third  generation  cephalosporins
ccording to  literature  guidelines  [12]  was  recorded
o be  87.5%.
revalence of MBL genes in clinical isolates
ut  of  356  isolates,  160  showed  resistance  to  the
ntibiotic  imipenem,  out  of  which  131  were  pheno-
ypically  positive  for  MBL  production.  Out  of  these
BL positive  isolates,  31  (23.6%)  were  found  to
arbor blaNDM-1 gene  by  PCR  ampliﬁcation  (Fig.  2)
here 13  were  K.  pneumoniae, 3 were  E.  coli  and  15
ere P.  aeruginosa.  These  isolates  came  from  dif-
erent patients,  sample  source,  and  hospital  wards
nd 18  were  from  inpatients  while  13  were  from
utpatients.  The  detailed  information  is  given  in
able  1. PCR  for  blaVIM showed  positive  result  for  33
490  F.  Nahid  et  al.
n  pr
b
f
wFigure  2  A  representative  gel  showing  PCR  ampliﬁcatio
molecular  size  marker  used  is  1000  bp  ladder.
(25.1%)  of  the  total  MBLs  positive  strains  where  21
were from  inpatient  and  12  were  from  outpatient.
Of total  MBL  producing  P.  aeruginosa  14  (36.8%)
were positive  for  blaVIM where  11  were  from  inpa-
tients and  3  were  from  outpatients.  Out  of  MBL
positive  K.  pneumoniae  11  (29.4%)  were  positive  for
f
o
E
Table  1  Data  of  patients,  sample  source  and  antibiotic  res
Sample  ID  Age  Gender  
2K.p  62  years  M  
3K.p  30  years  M  
4K.p  18  years  M  
5K.p  17  years  F  
8K.p  54  years  M  
9K.p  40  years  F  
12K.p  45  years  M  
22K.p  27  years  F  
27K.p  71  years  F  
29K.p  80  years  M  
42K.p  40  years F  
10E  40  years  F  
9  P.a  34  years  F  
10  P.a  55  years  F  
12  P.a 85  years  M  
17  P.a  60  years  F  
19  P.a  75  years  M  
22  P.a  85  years  M  
26  P.a  30  years  M  
29  P.a  29  years  M  
55  P.a  14  years  M  
61  P.a  45  years  M  
70  P.a  20  years  M  
71  P.a  50  years  M  
46  35  years  M  
44  36  years  F  
48  40  years  M  
52  49  years  F  
28  52  years  M  
23  46  years  F  
25  60  years  F  
ICU = intensive care unit, OPD = outpatient department, SW = surgicaoduct  of  blaNDM-1 gene  at  784  bp  in  clinical  isolates.  The
laVIM where  9  were  from  outpatients  and  2 were
rom inpatients.  Of  all  MBL  positive  E.  coli  8  (16%)
ere found  to  carry  blaVIM gene  and  they  all  were
rom inpatient.  Out  of  all  MBLs  positive  isolates,
nly two  were  positive  for  blaIMP gene  which  were
. coli.
istance  pattern  for  NDM-1  positive  isolates.
Specimen  Ward
Pus  MW2
CVP  tip  Medical  ICU
Pus  SW1
Blood  Gastroenterology  OPD
CVP  tip  Medical  ICU
High  vaginal  swab  Emergency  OPD
Pus  SW6
Blood  Medical  ICU
Urine  Nephrology  OPD
Urine  Plumnology  OPD
Pus  Emergency  OPD
Urine  MW1
Urine  MW1
Pus  Emergency  OPD
Catheter  tip  Emergency  OPD
Urine  Neurosurgery  OPD
Tracheal  secretions  Emergency  OPD
Tracheal  secretions  Emergency  OPD
Tissue  Medical  ICU
Pus  SW1
Tracheal  secretions  SW3
Pus  SW6
Tracheal  secretions  Medical  ICU
Catheter  tip  Cardiology  ward
Urine  OPD
Urine  OPD
Catheter  tip  Medical  ward
Urine  Medical  ward
Catheter  tip  Medical  ward
Urine  Medical  ward
Urine  OPD
l ward.
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Table  2  Antibiotic  resistance  pattern  of  subsets  of  NDM-1  positive,  NDM-1  negative  but  MBL  positive,  ESBL  positive
and  ESBL  negative  isolates.
Antibiotic  NDM-1  positive
(n  =  31)
NDM-1  negative  but
MBL  positive  (n  =  53)
ESBL  positive
(n  =  35)
ESBL  negative
(n  =  42)
Meropenem  96.7%  100%  20%  7.14%
Imipenem  96.7%  100%  20%  7.14%
Amoxicillin/calvulanic  acid 90.3%  54.7%  94.2%  80.9%
Ceftriaxone  93.5% 71.6%  91.4%  69%
Ceftazidime  96.7% 81.1%  91.4%  85.7%
Cefotaxime  90.3% 78%  88.5%  80.9%
Aztreonam  90.3%  54.7%  82.8%  64.2%
Amikacin  67.7%  54%  NT  NT
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NT = not tested.
lasmid proﬁle analysis
lasmid  proﬁle  analysis  showed  that  all  NDM-1  pos-
tive isolates  carried  plasmids  of  different  number
nd size  with  most  of  the  plasmids  displaying  a
ize of  >10  kb.  Plasmids  DNAs  were  ampliﬁed  to
heck  the  presence  of  blaNDM-1 gene  and  7  out  of  31
howed positive  result  for  blaNDM-1 gene.  Of  these
 isolates,  3  were  P.  aeruginosa, 2  were  E.  coli  and
 were  K.  pneumonia.
lasmid stability assay
e  assessed  plasmid  stability  by  serial  passage
f NDM-1  positive  isolates  on  antibiotic  free  and
.5 mg/L  meropenem  containing  media.  Passages
ere done  every  24  h up  to  15  passages.  All  the
lasmids remained  stable  up  to  passage  7.  Toward
he 8th  passage,  one  plasmid  of  Pseudomonas  was
ost while  at  10th  passage;  one  plasmid  of  E.  coli
as lost.  All  other  plasmids  remained  stable  upto15
assages.
ntimicrobial resistance proﬁle
he  resistance  against  third  generation  extended
pectrum cephalosporins  was  as  following:  cef-
azidime  (85.1%),  ceftriaxone  (83.5%),  cefotaxime
87.3%). Antimicrobial  resistance  pattern  of  31
laNDM-1 positive  isolates  were  as  following:
eropenem  (96.9%),  imipenem  (96.9%),  amoxi-
illin/calvulanic  acid  (90.3%),  ceftazidime  (96.9%),
eftriaxone  (93.5%),  cefotaxime  (90.3%),  aztre-
nam (90.3%),  amikacin  (67.7%),  and  colistin
3.2%). The  antibiotic  resistance  pattern  of  a  subset
f NDM-1  negative  but  MBL  positive  isolates  (n  =  53)
ere as  following:  meropenem  (100%),  imipenem
100%), amoxicillin/calvulanic  acid  (54.7%),  cef-
azidime (81.1%),  ceftriaxone  (71.6%),  cefotaxime
78%), cefuroxime  (30.1%),  aztreonam  (54.7%),
x
s
a
lNT  NT
mikacin  (54%),  norﬂoxacin  (35.8%),  polymyxin  B
0%), and  piperacillin/tazobactam  (5.6%).  The  com-
arative resistance  pattern  of  different  categories
f isolates  is  given  in  Table  2.
iscussion
ince  the  early  cases  recorded  from  India  and
akistan [3,4,6], NDM-1  positive  organisms  have
een reported  widely  [8,13—15]. We  report  here
he prevalence  of  NDM-1  producing  gram  negative
athogens at two  tertiary  care  hospitals  in  Pakistan.
f 356  isolates,  131  (36.7%)  produced  MBL,  out  of
hich 31  (23.6%)  were  found  to  be  positive  for
laNDM-1 by  PCR.  These  isolates  were  taken  from
ifferent types  of  specimen  such  as  tracheal  secret-
ons, urine,  blood,  catheter  tips,  CVP  tips,  and  pus
nd reﬂect  the  dissemination  of  NDM-1  in  pathogens
oming  from  different  sources.  The  plasmid  anal-
sis shows  that  blaNDM-1 gene  in  tested  isolates  is
arried by  different  plasmids  with  plasmid  carriage
f 22%.  Most  of  the  strains  carried  several  plasmids
hich were  of  >10  kb  in  size.
It was  also  observed  that  blaNDM-1 carrying  orga-
isms came  mostly  from  inpatients  as  compared
o outpatients.  This  suggests  that  NDM-1  posi-
ive pathogens  are  more  associated  with  carriage
solates than  the  infection  ones.  The  emergence
f NDM-1  positive  strains  presents  major  health
roblems as  these  strains  show  resistance  against
ommonly used  antibiotics,  leaving  the  clinicians
ith limited  options.  In  the  present  study,  most
f NDM-1  positive  strains  were  found  to  be  resis-
ant to  the  effects  of  meropenem,  imipenem,
moxicillin/calvulanic  acid,  ceftazidime,  ceftria-
one, cefotaxime  and  azetreonam  while  highest
usceptibility  was  observed  for  colistin  which  is  in
ccordance  with  the  prior  studies  [3,6,7]. The  iso-
ates showed  32.2%  susceptibility  to  amikacin  which
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relates  to  the  ﬁndings  of  Poirel  et  al.,  [16]  where
a single  E.  coli  strain  was  found  susceptible  to  the
effects  of  amikacin.  This  is  an  interesting  obser-
vation since  most  NDM-1  isolates  also  carry  16S
methylase  genes  giving  resistance  to  all  aminogly-
cosides. This  suggests  this  combination  is  not  yet
common  in  Pakistan  and  amikacin  can  be  effective
in treating  such  strains  but  it  should  be  considered
that its  use  is  tightly  regulated  to  avoid  develop-
ment of  resistance  against  this  antibiotic.
Besides  blaNDM-1,  the  study  also  detected  the
presence of  blaIMP and  blaVIM in  MBL  producing
organisms  and  found  25.1%  blaVIM and  1.5%  blaIMP
containing  organisms.  In  a  recent  study  from  India,
the prevalence  of  blaVIM was  reported  to  be  18.6%  in
carbapenem  resistant  gram-negative  bacteria  [17]
and  in  another  it  was  reported  to  be  61.8%  in  MBL
producing  bacteria  [18]. The  difference  in  preva-
lence  rates  could  be  due  to  the  difference  of  sample
size studied.  The  prevalence  rate  of  blaIMP corre-
lated with  the  report  from  India  [18].
The study  also  detected  the  production  of  ESBLs
and MBLs  by  phenotypic  tests.  For  an  overall  preva-
lence of  MBLs,  we  found  33.9%  MBL  producing  P.
aeruginosa  which  is  lower  than  another  report  from
Pakistan  where  it  was  reported  to  be  59.5%  [19].  On
the other  hand,  in  the  same  year,  it  was  reported
to be  8.05%  in  a  study  conducted  in  India  [20].  The
MBL producing  K.  pneumonia  were  45%  and  sporadic
MBLs  producing  K.  pneumonia  have  been  reported
globally [21—23].  For  E.  coli,  the  prevalence  of  MBL
was found  to  be  34.4%  which  is  alarmingly  high.  This
high prevalence  requires  immediate  consideration.
In another  study,  a  high  prevalence  of  up  to  41%  MBL
producing  E.  coli  strains  was  reported  [24].
In our  setup  the  high  rate  of  MBL  producing
pathogens  could  be  due  to  poor  hygiene  conditions
and irrational  use  of  broad  spectrum  antibiotics
and this  irrational  use  would  have  left  only  car-
bapenems  to  be  the  effective  antibiotics  which  are
starting to  be  ineffective  as  well.  The  data  about
the mortality  rate  in  these  health  care  facilities  is
not available  so  we  cannot  comment  on  whether  the
mortality  rate  has  been  affected  by  these  resistant
pathogens or  not.
Conclusions
A  considerable  prevalence  of  blaNDM-1 carrying  gram
negative pathogens  in  patients  coming  to  PIMS  and
Mayo Hospitals  indicates  the  need  for  the  coun-
trywide  screening  of  hospitals  and  community  to
evaluate  the  exact  prevalence  of  blaNDM-1 carry-
ing pathogens  in  Pakistan.  A  protocol  should  be
introduced  in  hospitals  if  such  a  case  may  occur.F.  Nahid  et  al.
lso,  to  avoid  the  risk  of  hospital  acquired  and
atient to  patient  spread  of  these  pathogens,
roper hygiene  should  be  implemented.  Regular
raining of  nursing  staff  should  be  practiced  so  the
pread of  pathogens  can  be  decreased.
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